Restricted accessBrief reportFirst published online 2020-5
Combined Partial Gastrectomy,Splenectomy,and Microwave Liver Ablation of Metastatic Gastrointestinal Stromal Tumor After 4 Years of Neoadjuvant Imatinib
MiettinenM.SobinLH.LasotaJ. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52-68.doi:10.1097/01.pas.0000146010.92933.dehttp://www.ncbi.nlm.nih.gov/pubmed/15613856
2.
JoensuuH.RobertsPJ.Sarlomo-RikalaMet al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344(14):1052-1056.doi:10.1056/NEJM200104053441404http://www.ncbi.nlm.nih.gov/pubmed/11287975
3.
RutkowskiP.GronchiA.HohenbergerPet al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937-2943.doi:10.1245/s10434-013-3013-7http://www.ncbi.nlm.nih.gov/pubmed/23760587
4.
GoldJS.DematteoRP. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance. Ann Surg Oncol. 2007;14(4):1247-1248.doi:10.1245/s10434-006-9291-6http://www.ncbi.nlm.nih.gov/pubmed/17265116
